Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dermatology

Free Subscription 20.05.2024 1 Am J Pathol 2 BMC Cancer 32 Br J Dermatol 1 Cancer 1 Cancer Lett 1 Cancer Res 10 Clin Exp Dermatol 6 Int J Cancer 9 Int J Dermatol 3 Intern Med 6 J Cutan Pathol 1 J Dermatol 4 J Invest Dermatol 3 Lancet 1 N Engl J Med 1 Plast Reconstr Surg 1 PLoS Comput Biol 14 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. JANA S, Li W, Lei PJ, Wang Z, et al
   Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone Receptor Expression, Human Epidermal Growth Factor Receptor 2 Positivity, and Enrichment in Cancer and Mesenchymal Stem Cells.
   Am J Pathol. 2024;194:1137-1153.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. HAUNER D, Mang A, Donik L, Schederecker F, et al
   Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
   BMC Cancer. 2024;24:591.
   PubMed         Abstract available
   
   
3. MIAO L, Miao T, Zhang Y, Hao J, et al
   Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
   BMC Cancer. 2024;24:602.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

4. MARONESE CA, Marzano AV
   Identifying candidates for early intervention in hidradenitis suppurativa.
   Br J Dermatol. 2024;190:787-788.
   PubMed        
   
   
5. RAGAMIN A, Zhang J, Pasmans SGMA, Schappin R, et al
   The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
   Br J Dermatol. 2024;190:867-875.
   PubMed         Abstract available
   
   
6. TORRE-CASTRO J, Rodriguez M, Alonso-Alonso R, Mendoza Cembranos MD, et al
   LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.
   Br J Dermatol. 2024;190:876-884.
   PubMed         Abstract available
   
   
7. KJAERSGAARD ANDERSEN R, Pedersen O, Eidsmo L, Jemec G, et al
   Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS.
   Br J Dermatol. 2024;190:904-914.
   PubMed         Abstract available
   
   
8. FORKEL S, Schubert S, Corvin L, Heine G, et al
   Contact allergies to dental materials in patients.
   Br J Dermatol. 2023 Dec 20:ljad525. doi: 10.1093.
   PubMed         Abstract available
   
   
9. CHIESA FUXENCH ZC
   The burden of atopic dermatitis across paediatric populations: 'it's not just an itch that rashes'.
   Br J Dermatol. 2024;190:783-784.
   PubMed        
   
   
10. MISTRY K, Venables ZC
    A systematic review of Merkel cell carcinoma epidemiology highlights its rising incidence, poor prognosis and data heterogeneity.
    Br J Dermatol. 2024;190:782-783.
    PubMed        
    
    
11. MOHSEN ST, Price EL, Chan AW, Hanna TP, et al
    Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies.
    Br J Dermatol. 2024;190:811-824.
    PubMed         Abstract available
    
    
12. OLSEN CM
    Ecological evidence for melanoma overdiagnosis in Denmark.
    Br J Dermatol. 2024 May 16:ljae206. doi: 10.1093.
    PubMed        
    
    
13. DU J, Dong C, Lin J, Lu X, et al
    MMP2hi Fibroblasts Regulate CD8+ T Cell Residency and Inflammation via CD100 in Psoriasis.
    Br J Dermatol. 2024 May 16:ljae205. doi: 10.1093.
    PubMed         Abstract available
    
    
14. HAMMAS K, Nardin C, Boyer S, Michel C, et al
    Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
    Br J Dermatol. 2024 May 15:ljae201. doi: 10.1093.
    PubMed         Abstract available
    
    
15. TANAHASHI K, Kono M, Yoshikawa T, Suzuki Y, et al
    Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin.
    Br J Dermatol. 2024 May 13:ljae193. doi: 10.1093.
    PubMed         Abstract available
    
    
16. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    PubMed        
    
    
17. PARRAGA SP, Feldman SR
    Insulin resistance and psoriasis.
    Br J Dermatol. 2024 May 13:ljae199. doi: 10.1093.
    PubMed        
    
    
18. BOITOR RA, Varma S, Sharma A, Odedra S, et al
    Diagnostic accuracy of autofluorescence-Raman spectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinoma.
    Br J Dermatol. 2024 May 13:ljae196. doi: 10.1093.
    PubMed         Abstract available
    
    
19. PASSERON T, Reinhardt M, Ehst B, Weiss J, et al
    Secukinumab in adult patients with lichen planus: Efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study.
    Br J Dermatol. 2024 May 13:ljae181. doi: 10.1093.
    PubMed         Abstract available
    
    
20. GREKOWITZ E, Metz M, Altrichter S, Bauer A, et al
    Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.
    Br J Dermatol. 2024;190:825-835.
    PubMed         Abstract available
    
    
21. JOHNSON O
    Living with nodular prurigo.
    Br J Dermatol. 2024;190:915.
    PubMed        
    
    
22. CHOI SR, Shin A, Ha YJ, Lee YJ, et al
    All-cause and cause-specific mortality in patients with Behcet disease versus the general population.
    Br J Dermatol. 2024;190:858-866.
    PubMed         Abstract available
    
    
23. GORDON ER, Trager MH, Kontos D, Weng C, et al
    Ethical considerations for artificial intelligence in dermatology: a scoping review.
    Br J Dermatol. 2024;190:789-797.
    PubMed         Abstract available
    
    
24. LEE S, Wei ET, Selescu T, Babes A, et al
    Histamine- and pruritogen-induced itch is inhibited by a TRPM8 agonist: a randomized vehicle-controlled human trial.
    Br J Dermatol. 2024;190:885-894.
    PubMed         Abstract available
    
    
25. LIAO V, Cornman HL, Ma E, Kwatra SG, et al
    Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
    Br J Dermatol. 2024;190:798-810.
    PubMed         Abstract available
    
    
26. BAHAR F, DeCaprio JA
    Why do we distinguish between virus-positive and virus-negative Merkel cell carcinoma?
    Br J Dermatol. 2024;190:785-786.
    PubMed        
    
    
27. KIM DY
    Mortality landscape of Behcet disease.
    Br J Dermatol. 2024;190:784.
    PubMed        
    
    
28. ZOUBOULIS CC, Passeron T, Pariser D, Wozniak MB, et al
    Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
    Br J Dermatol. 2024;190:836-845.
    PubMed         Abstract available
    
    
29. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    PubMed        
    
    
30. THANG CJ, Garate D, O'Leary S, Golovko G, et al
    Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
    Br J Dermatol. 2024;190:921-923.
    PubMed        
    
    
31. PAVLENKO D, Akiyama T
    Cryosim-1: a cool solution for acute and chronic itch.
    Br J Dermatol. 2024;190:787.
    PubMed        
    
    
32. 
    Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review.
    Br J Dermatol. 2024;190:e64.
    PubMed        
    
    
33. 
    The impact of atopic dermatitis on children and adolescents.
    Br J Dermatol. 2024;190:e65.
    PubMed        
    
    
34. 
    Predicting the likelihood of hidradenitis suppurativa disease progression based on identified risk factors.
    Br J Dermatol. 2024;190:e67.
    PubMed        
    
    
35. 
    Contact allergies to dental material.
    Br J Dermatol. 2024;190:e66.
    PubMed        
    
    

    
    Cancer

36. NGUYEN SM, Tran HTT, Long J, Shrubsole MJ, et al
    Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer.
    Cancer. 2024 Feb 6. doi: 10.1002/cncr.35229.
    PubMed         Abstract available
    
    

    
    Cancer Lett

37. RIVERA-RAMOS A, Cruz-Hernandez L, Talaveron R, Sanchez-Montero MT, et al
    Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth.
    Cancer Lett. 2024;591:216879.
    PubMed         Abstract available
    
    

    
    Cancer Res

38. WANG Z, Zhang N, Zhang M, Jiang Y, et al
    GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner.
    Cancer Res. 2023 Jul 18:CAN-22-3471. doi: 10.1158/0008-5472.CAN-22-3471.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

39. MATTHEWMAN J, Mulick A, Dand N, Major-Smith D, et al
    Disagreement concerning atopic dermatitis subtypes between an English prospective cohort (ALSPAC) and linked electronic health records.
    Clin Exp Dermatol. 2024 May 16:llae196. doi: 10.1093.
    PubMed         Abstract available
    
    
40. RAZA SA, Cannon D, Ali FR
    Gaining exposure on perceptions of sunscreen: a national survey of melanoma patients.
    Clin Exp Dermatol. 2024 May 16:llae179. doi: 10.1093.
    PubMed         Abstract available
    
    
41. FATHIMA S, Grainge MJ, Wainman H, Swiderski M, et al
    Risk factors for the development of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, following drug administration: a systematic review and meta-analysis.
    Clin Exp Dermatol. 2024 May 15:llae183. doi: 10.1093.
    PubMed        
    
    
42. ABDUL GAFOOR SM, Robinson S, Diskantova S, Woodcock E, et al
    Patient-initiated follow-up for high-risk cutaneous squamous cell carcinoma. How we do it and two years of outcome data.
    Clin Exp Dermatol. 2024 May 15:llae160. doi: 10.1093.
    PubMed         Abstract available
    
    
43. AGRAWAL S, Arava S, Mehta N
    Recalcitrant acneiform papules on the face.
    Clin Exp Dermatol. 2024 May 15:llae200. doi: 10.1093.
    PubMed        
    
    
44. ALGARIN YA, Pulumati A, Reznik A, Pariser RJ, et al
    YouTube as a Source of Information for Self-Skin Examinations: An Analysis of Content and Quality.
    Clin Exp Dermatol. 2024 May 14:llae190. doi: 10.1093.
    PubMed        
    
    
45. PARKS EA, Zaino ML, Trettin B, Feldman SR, et al
    Qualitative investigation of disease course, characteristics and lived experience of generalized pustular psoriasis.
    Clin Exp Dermatol. 2024 May 13:llae194. doi: 10.1093.
    PubMed         Abstract available
    
    
46. ZENGARINI C, Guglielmo A, Bandini G, Filippini A, et al
    Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis.
    Clin Exp Dermatol. 2024 May 13:llae189. doi: 10.1093.
    PubMed         Abstract available
    
    
47. ZHANG L, Huang X, Cheng Q, Lei X, et al
    Epithelioid sarcoma: a rare cause of refractory chronic skin ulcers.
    Clin Exp Dermatol. 2024 May 13:llae182. doi: 10.1093.
    PubMed        
    
    
48. GRANT C, Perez-Chada LM, Harrison RW, McLean RR, et al
    Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis Registry.
    Clin Exp Dermatol. 2024 Mar 5:llae095. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

49. HWANG HW, Shin HT, An HY, Byun JW, et al
    Genomic progression for local invasion of cutaneous squamous cell carcinoma from the superficial to the deep portion.
    Int J Cancer. 2024 May 13. doi: 10.1002/ijc.34952.
    PubMed         Abstract available
    
    
50. WANG T, Chai B, Chen WY, Holmes MD, et al
    Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Int J Cancer. 2024 Mar 22. doi: 10.1002/ijc.34917.
    PubMed         Abstract available
    
    
51. DAL MASO L, Toffolutti F, De Paoli A, Giudici F, et al
    Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
    Int J Cancer. 2024 Mar 23. doi: 10.1002/ijc.34923.
    PubMed         Abstract available
    
    
52. SONGISO M, Nunez O, Cabanes A, Mutale M, et al
    Three-year survival of breast cancer patients attending a one-stop breast care clinic nested within a primary care health facility in sub-Saharan Africa-Zambia.
    Int J Cancer. 2024 Mar 25. doi: 10.1002/ijc.34920.
    PubMed         Abstract available
    
    
53. WU H, Wang W, Zhang Y, Chen Y, et al
    Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
    Int J Cancer. 2024 Mar 27. doi: 10.1002/ijc.34931.
    PubMed         Abstract available
    
    
54. GABRIELSON M, Hammarstrom M, Bergqvist J, Lang K, et al
    Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change.
    Int J Cancer. 2024;155:339-351.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

55. BHAT K, Patra S, Bhardwaj A, Singh S, et al
    Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer-blinded comparative study.
    Int J Dermatol. 2024 May 17. doi: 10.1111/ijd.17185.
    PubMed         Abstract available
    
    
56. MUSSI M, Zengarini C, Chessa MA, Gelmetti A, et al
    Granular parakeratosis: dermoscopic findings of an uncommon dermatosis.
    Int J Dermatol. 2024 May 17. doi: 10.1111/ijd.17253.
    PubMed        
    
    
57. OLLECH A, Cohen-Barak E, Horev A, Bar-Ilan E, et al
    Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study.
    Int J Dermatol. 2024 May 15. doi: 10.1111/ijd.17198.
    PubMed        
    
    
58. MASTORINO L, Dapavo P, Macagno N, Ortoncelli M, et al
    Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents.
    Int J Dermatol. 2024 May 15. doi: 10.1111/ijd.17252.
    PubMed         Abstract available
    
    
59. LUGLI AP, Gori N, Chiricozzi A, Boschetti G, et al
    Clinical effectiveness of combined dupilumab and baricitinib in a patient with multi-drug resistant severe atopic dermatitis.
    Int J Dermatol. 2024 May 15. doi: 10.1111/ijd.17250.
    PubMed        
    
    
60. HOSHINA D, Kimura A
    Cutaneous T-cell pseudolymphoma successfully treated with topical delgocitinib.
    Int J Dermatol. 2024 May 14. doi: 10.1111/ijd.17239.
    PubMed        
    
    
61. VINAY K, Baskaran N, Narang T, Dogra S, et al
    Utility of cutaneous thermography in assessment of nerve function impairment in leprosy.
    Int J Dermatol. 2024 May 13. doi: 10.1111/ijd.17248.
    PubMed        
    
    
62. SAHUQUILLO-TORRALBA A, Mansilla-Polo M, Pujol-Marco C, Llamas-Velasco M, et al
    Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group.
    Int J Dermatol. 2024 May 12. doi: 10.1111/ijd.17238.
    PubMed         Abstract available
    
    
63. LICATA G, Rizzo D, Frazzitta M, Zichichi L, et al
    Successful treatment of sub-erythrodermic psoriasis with bimekizumab: a case report and literature review.
    Int J Dermatol. 2024 May 12. doi: 10.1111/ijd.17109.
    PubMed        
    
    

    
    Intern Med

64. UMEMOTO D, Kanzawa Y, Nakamura T, Nishino I, et al
    Immune-mediated Necrotizing Myopathy in a Patient with Microscopic Polyangiitis.
    Intern Med. 2024;63:1485-1490.
    PubMed         Abstract available
    
    
65. OTSUKA Y, Tanizaki R, Nomura Y
    Leukocytoclastic Vasculitis Secondary to Severe Fever with Thrombocytopenia Syndrome.
    Intern Med. 2024;63:1479-1483.
    PubMed         Abstract available
    
    
66. SAITO K, Temmoku J, Sumichika Y, Yoshida S, et al
    Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy.
    Intern Med. 2024;63:1473-1478.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

67. PERRIN C, Coutts M
    Onychomatricoma is not a subtype of superficial acral fibromyxoma: Can immunohistochemistry help in the differential diagnosis?
    J Cutan Pathol. 2024;51:439-440.
    PubMed        
    
    
68. GRAU-ECHEVARRIA A, Labrandero-Hoyos C, Penuelas-Leal R, Finello M, et al
    Anetoderma after disseminated Mpox.
    J Cutan Pathol. 2024;51:415-418.
    PubMed         Abstract available
    
    
69. CHUNG C, Wu B, LeWitt T, Griffin T, et al
    Interstitial mycosis fungoides: A rare presentation of mycosis fungoides with overlapping granulomatous and folliculotropic features.
    J Cutan Pathol. 2024;51:459-467.
    PubMed         Abstract available
    
    
70. GOTO K, Kiniwa Y, Hishima T, Honma K, et al
    PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases.
    J Cutan Pathol. 2024;51:399-402.
    PubMed        
    
    
71. TURCIOS ESCOBAR S, Yang R, Nelson KC, Gershenwald JE, et al
    Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case report.
    J Cutan Pathol. 2024 May 16. doi: 10.1111/cup.14660.
    PubMed         Abstract available
    
    
72. HUANG C, Runge M, Hrycaj SM, Harms PW, et al
    Proliferating inverted follicular keratosis of genital skin: Case series of a challenging variant.
    J Cutan Pathol. 2024 May 12. doi: 10.1111/cup.14644.
    PubMed         Abstract available
    
    

    
    J Dermatol

73. TADA Y, Sugiura Y, Kamishima M, Tanaka Y, et al
    Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
    J Dermatol. 2024 May 15. doi: 10.1111/1346-8138.17255.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

74. XIAO W, Sha K, Wang M, Tan Z, et al
    SERPINB3/B4 is Increased in Psoriasis and Rosacea Lesions and has Pro-inflammatory Effects in Mouse Models of these Diseases.
    J Invest Dermatol. 2024 May 10:S0022-202X(24)00367.
    PubMed         Abstract available
    
    
75. HAYES J, Higgins CA
    Plantar Skin: A Callus Design?
    J Invest Dermatol. 2024 May 13:S0022-202X(24)00273.
    PubMed        
    
    
76. GREENSPAN LJ, Cisneros I, Weinstein BM
    Dermal Dive: An Overview of Cutaneous Wounding Techniques in Zebrafish.
    J Invest Dermatol. 2024 May 15:S0022-202X(24)00309.
    PubMed         Abstract available
    
    
77. BORZUTZKY A, Cabalin C
    From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
    J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
    PubMed        
    
    

    
    Lancet

78. MOODLEY J, Unger-Saldana K
    The role of racial and ethnic discrimination in breast cancer disparities.
    Lancet. 2024 Apr 12:S0140-6736(24)00699-8. doi: 10.1016/S0140-6736(24)00699.
    PubMed        
    
    
79. COLES CE, Earl H, Anderson BO, Barrios CH, et al
    The Lancet Breast Cancer Commission.
    Lancet. 2024 Apr 12:S0140-6736(24)00747-5. doi: 10.1016/S0140-6736(24)00747.
    PubMed        
    
    
80. SAMARASEKERA U
    Charlotte Coles: collaborating to tackle breast cancer inequities.
    Lancet. 2024 Apr 12:S0140-6736(24)00752-9. doi: 10.1016/S0140-6736(24)00752.
    PubMed        
    
    

    
    N Engl J Med

81. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed        
    
    

    
    Plast Reconstr Surg

82. WONG CH, Hsieh MKH
    Medial Epicanthoplasty with the Skin Re-Draping Technique: Technical Refinements for Predictable outcomes.
    Plast Reconstr Surg. 2024 May 14. doi: 10.1097/PRS.0000000000011533.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

83. BENZEKRY S, Mastri M, Nicolo C, Ebos JML, et al
    Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment.
    PLoS Comput Biol. 2024;20:e1012088.
    PubMed         Abstract available
    
    

    
    PLoS One

84. KIM SM, Park N, Park HB, Lee J, et al
    Exploring novel immunotherapy biomarker candidates induced by cancer deformation.
    PLoS One. 2024;19:e0303433.
    PubMed         Abstract available
    
    
85. LUU TNN, Dinh DX, Tran TX, Tran TB, et al
    Health-state utility of patients with HER2-positive breast cancer in Vietnam: A multicenter cross-sectional study.
    PLoS One. 2024;19:e0303011.
    PubMed         Abstract available
    
    
86. XU Y, Yu J, Shen R, Shan X, et al
    Comparison efficacy and safety of acupuncture and moxibustion therapies in breast cancer-related lymphedema: A systematic review and network meta-analysis.
    PLoS One. 2024;19:e0303513.
    PubMed         Abstract available
    
    
87. MUNTER-YOUNG R, Fuentes-Alburo A, DiGregorio N, Neeser K, et al
    Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
    PLoS One. 2024;19:e0302486.
    PubMed         Abstract available
    
    
88. PEZARO S, Brock I, Buckley M, Callaway S, et al
    Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.
    PLoS One. 2024;19:e0302401.
    PubMed         Abstract available
    
    
89. XIAO J, Tan L, Pei Y, Yang R, et al
    Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
    PLoS One. 2024;19:e0302414.
    PubMed         Abstract available
    
    
90. SAITO N, Matsuo T, Tsuda H, Yokota H, et al
    Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray.
    PLoS One. 2024;19:e0303614.
    PubMed         Abstract available
    
    
91. PINTO-CARBO M, Vanaclocha-Espi M, Ibanez J, Martin-Pozuelo J, et al
    Interaction of sedentary behaviour and educational level in breast cancer risk.
    PLoS One. 2024;19:e0300349.
    PubMed         Abstract available
    
    
92. YANG Z, Wang Y, Huang S, Geng Y, et al
    Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
    PLoS One. 2024;19:e0303650.
    PubMed         Abstract available
    
    
93. ZHONG X, Shang J, Zhang R, Zhang X, et al
    Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.
    PLoS One. 2024;19:e0296034.
    PubMed         Abstract available
    
    
94. SHERIEF HH, Zaky MF, Abbas MF, Mahrous SA, et al
    Mathematical modeling of heat transfer in tissues with skin tumor during thermotherapy.
    PLoS One. 2024;19:e0298256.
    PubMed         Abstract available
    
    
95. PELICANO AC, Goncalves MCT, Castela T, Orvalho ML, et al
    Repository of MRI-derived models of the breast with single and multiple benign and malignant tumors for microwave imaging research.
    PLoS One. 2024;19:e0302974.
    PubMed         Abstract available
    
    
96. SUN G, Cai L, Yan X, Nie W, et al
    A prediction model based on digital breast pathology image information.
    PLoS One. 2024;19:e0294923.
    PubMed         Abstract available
    
    
97. BARAL P, Afnan N, Ahmad Zahra M, Akter B, et al
    Bacteriological analysis and antibiotic resistance in patients with diabetic foot ulcers in Dhaka.
    PLoS One. 2024;19:e0301767.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.